AbCellera Biologics Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Vancouver, British Columbia, Canada
ABCL chart
What traders are saying about $ABCL
Latest postsAbCellera Biologics Inc. news
- Did Positive Phase 2 Results Just Shift AbCellera Biologics' (ABCL) Investment Narrative?
Simply Wall Street ·
- AbCellera Biologics (Nasdaq:ABCL) - Stock Analysis
Simply Wall Street ·
- AbCellera Biologics Inc. Estimates – NASDAQ:ABCL
TradingView ·
- Is AbCellera Biologics (ABCL) Undervalued After Encouraging Phase 2 Data For ABCL635?
Simply Wall Street ·
- AbCellera to Present at Upcoming Investor Conferences in November 2026
Yahoo Finance ·
- AbCellera Biologics Is Up 124% Even As Sales Fell
Simply Wall Street ·
- AbCellera Has Promising Menopause Data But Much Of The Opportunity Is Priced In (ABCL)
Seeking Alpha ·
- Nurix Therapeutics, Inc. (NRIX) Q3 Earnings and Revenues Surpass Estimates
Yahoo Finance ·
- AbCellera Biologics (ABCL) Could Be 27% Undervalued As ABCL635 Data Draws Focus
Yahoo Finance ·
- What Could Go Wrong With Recursion Pharmaceuticals Stock?
trefis.com ·
- AbCellera Announces Presentation of Phase 1/2 Data for ABCL635 at TMS 2026 Annual Meeting
Yahoo Finance ·
- AbCellera to Report Third Quarter 2026 Financial Results on November 9, 2026
Yahoo Finance ·
AbCellera Biologics Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $75.1M | $28.8M | $38.0M | $485.4M |
| Net income | -$146.4M | -$162.9M | -$146.4M | $158.5M |
| Diluted EPS | $-0.49 | $-0.55 | $-0.51 | $0.50 |
| Total assets (year end) | $1.36B | $1.36B | $1.49B | $1.54B |
| Cash and equivalents (year end) | $128.5M | $156.3M | $133.3M | $386.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About AbCellera Biologics Inc.
- Ticker
- ABCL (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Vancouver, British Columbia, Canada
- Incorporated in
- British Columbia, Canada
- Fiscal year end
- December 31
- SEC CIK
- 1703057
Frequently asked questions
What exchange is AbCellera Biologics Inc. listed on?
AbCellera Biologics Inc. trades on the Nasdaq under the ticker symbol ABCL.
What industry is AbCellera Biologics Inc. in?
AbCellera Biologics Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is AbCellera Biologics Inc. headquartered?
AbCellera Biologics Inc.'s business address on file with the SEC is in Vancouver, British Columbia, Canada.
When does AbCellera Biologics Inc.'s fiscal year end?
AbCellera Biologics Inc.'s fiscal year ends on December 31.
How much revenue did AbCellera Biologics Inc. report?
AbCellera Biologics Inc. reported $75.1M in revenue for calendar year 2025, according to its SEC filings.